Private funding cannot replace public funding of science because companies pursue profit and do not always address the greatest social needs[1]. An example is Big Pharma, which neglects diseases affecting poor people[1]. Public funding makes it possible to focus on public needs and support long-term projects lasting years or decades, such as mapping the US coastline or the human genome[1]. John R. Steelman, an assistant to President Harry Truman, emphasized the importance of federal funding for research at both universities and state institutions in his 1947 report Science and Public Policy[1]. Steelman distinguished four types of science: basic, supporting, applied and developmental [1]. Currently, due to cuts in the US under the Trump administration, a task force on strategic partnerships with pharmaceutical companies has been created at the Harvard School of Public Health[1]. Some argue that private funding is more flexible and less prone to groupthink[1].